{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:06:11Z","timestamp":1792195571951,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuint.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T03:09:51Z","timestamp":1522984191000},"page":"252-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Restorative effect of l-Dopa treatment against Ochratoxin A induced neurotoxicity"],"prefix":"10.1016","volume":"118","author":[{"given":"Pratiksha V.","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mohan Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhath","family":"Khanum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/bmc.1130070605","article-title":"A sensitive and rapid HPLC-ECD method for the simultaneous analysis of norepinephrine, dopamine, serotonin and their primary metabolites in brain tissue","volume":"7","author":"Alburges","year":"1993","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)80086-0","article-title":"Atm-deficient mice: a paradigm of ataxia telangiectasia","volume":"86","author":"Barlow","year":"1996","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neuint.2018.04.003_bib4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s002040050557","article-title":"Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain","volume":"72","author":"Belmadani","year":"1998","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.neuint.2018.04.003_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bies.10067","article-title":"Animal models of Parkinson's disease","volume":"24","author":"Betarbet","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.neuint.2018.04.003_bib6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fmicb.2016.01142","article-title":"Cytotoxic effects of ochratoxin a in Neuro-2a cells: role of oxidative stress evidenced by N-acetylcysteine","volume":"7","author":"Bhat","year":"2016","journal-title":"Front. Microbiol."},{"issue":"49","key":"10.1016\/j.neuint.2018.04.003_bib7","doi-asserted-by":"crossref","first-page":"46017","DOI":"10.1074\/jbc.M105564200","article-title":"Nitration and inactivation of tyrosine hydroxylase by peroxynitrite","volume":"276","author":"Blanchard-Fillion","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuint.2018.04.003_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.neubiorev.2013.03.007","article-title":"Behavioral testing regimens in genetic-based animal models of Parkinson's disease: cogencies and caveats","volume":"37","author":"Bury","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1749-6632.1998.tb09924.x","article-title":"Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-Butyl-\u03b1-phenylnitrone and vitamin Ea","volume":"854","author":"Butterfield","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0531-5565(00)00197-2","article-title":"Relation of oxidative protein damage and nitrotyrosine levels in the aging rat brain","volume":"36","author":"Cakatay","year":"2001","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0031-6997(25)07428-9","article-title":"The occurrence, distribution and physiological role of catecholamines in the nervous system","volume":"11","author":"Carlsson","year":"1959","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/mnfr.200500182","article-title":"Balkan endemic nephropathy: role of ochratoxins A through biomarkers","volume":"50","author":"Castegnaro","year":"2006","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.neuint.2018.04.003_bib13","series-title":"Metabolism of Amino Acids and Amines. Monoamine Oxidase (Human Serum\/plasma and Rabbit Serum). Methods in Enzymology","first-page":"686","volume":"XVIIIB","author":"Charles","year":"1971"},{"issue":"5","key":"10.1016\/j.neuint.2018.04.003_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2982.2008.01226.x","article-title":"Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism","volume":"21","author":"Chaumette","year":"2009","journal-title":"Neuro Gastroenterol. Motil."},{"issue":"4","key":"10.1016\/j.neuint.2018.04.003_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0892-0362(90)90061-G","article-title":"Effects of MPTP on locomotor activity in mice","volume":"12","author":"Colotla","year":"1990","journal-title":"Neurotoxicol. Teratol."},{"issue":"14","key":"10.1016\/j.neuint.2018.04.003_bib89","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/0006-2952(72)90006-8","article-title":"Tyrosine hydroxylase in rat brain\u2014cofactor requirements, regional and subcellular distribution","volume":"21","author":"Coyle","year":"1972","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0005-2787(81)90095-2","article-title":"In vitro inhibition of yeast valyl-tRNA synthetase by the valine homologue of ochratoxin A","volume":"656","author":"Creppy","year":"1981","journal-title":"Biochim. Biophys. Acta Nucleic Acids Protein Synth."},{"issue":"11","key":"10.1016\/j.neuint.2018.04.003_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0278-6915(84)90170-4","article-title":"Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine","volume":"22","author":"Creppy","year":"1984","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2018.04.003_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1028415X.2017.1357793","article-title":"Role of mycotoxins in the pathobiology of autism: a first evidence","author":"De Santis","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuint.2018.04.003_bib21","article-title":"Measuring motor coordination in mice","volume":"75","author":"Deacon","year":"2013","journal-title":"JoVE"},{"key":"10.1016\/j.neuint.2018.04.003_bib22","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1016\/S1353-8020(09)70822-3","article-title":"Update on models of basal ganglia function and dysfunction","volume":"15","author":"DeLong","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"04","key":"10.1016\/j.neuint.2018.04.003_bib23","first-page":"258","article-title":"Inhibition of MAO and GABA: probable mechanisms for antidepressant-like activity of Nardostachys jatamansi DC. in mice","volume":"48","author":"Dhingra","year":"2008","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.neuint.2018.04.003_bib24","first-page":"171","article-title":"Mechanism of action of ochratoxin A","volume":"115","author":"Dirheimer","year":"1991","journal-title":"IARC (Int. Agency Res. Cancer) Sci. Publ."},{"issue":"4","key":"10.1016\/j.neuint.2018.04.003_bib25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0270(01)00485-X","article-title":"A simple method to measure stride length as an index of nigrostriatal dysfunction in mice","volume":"113","author":"Fernagut","year":"2002","journal-title":"J. Neurosci. Meth."},{"issue":"4","key":"10.1016\/j.neuint.2018.04.003_bib28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0306-4522(02)00778-9","article-title":"Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice","volume":"116","author":"Fernagut","year":"2003","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.neuint.2018.04.003_bib29","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and \u03b1-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.neuint.2018.04.003_bib30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0891-5849(01)00507-X","article-title":"Oxidative damage and stress response from ochratoxin A exposure in rats","volume":"30","author":"Gautier","year":"2001","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/gbb.12210","article-title":"Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice","volume":"14","author":"Gellhaar","year":"2015","journal-title":"Gene Brain Behav."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.07.026","article-title":"Levodopa delivery systems for the treatment of Parkinson's disease: an overview","volume":"380","author":"Goole","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3200\/JMBR.40.6.568-577","article-title":"Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis","volume":"40","author":"Guillot","year":"2008","journal-title":"J. Mot. Behav."},{"issue":"4587","key":"10.1016\/j.neuint.2018.04.003_bib34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to product of meperidine-analog synthesis","volume":"219","author":"Hala","year":"1983","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/tera.1420090112","article-title":"Teratogenic effects of ochratoxin A in mice","volume":"9","author":"Hayes","year":"1974","journal-title":"Teratology"},{"issue":"10","key":"10.1016\/j.neuint.2018.04.003_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-2236(80)80070-1","article-title":"l-DOPA's mechanism of action in Parkinson's disease","volume":"3","author":"Hefti","year":"1980","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12031-013-0208-0","article-title":"EPO-dependent activation of PI3K\/Akt\/FoxO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease","volume":"53","author":"Jia","year":"2014","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/00207450590881542","article-title":"Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor","volume":"115","author":"Jingzhong","year":"2005","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"11","author":"Kowall","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2018.04.003_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0166-2236(85)90031-1","article-title":"MPTP and Parkinson's disease","volume":"8","author":"Langston","year":"1985","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.neuint.2018.04.003_bib43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/jcbfm.2009.102","article-title":"Involvement of the PTEN\u2013AKT\u2013FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia\u2013ischemia","volume":"29","author":"Li","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/toxsci\/kfg073","article-title":"A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays","volume":"73","author":"L\u00fche","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.neuint.2018.04.003_bib46","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.fct.2007.05.021","article-title":"Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats","volume":"45","author":"Mally","year":"2007","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib47","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0014-4886(79)90107-9","article-title":"Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: apomorphine-induced reversal of deficits","volume":"65","author":"Marshall","year":"1979","journal-title":"Exp. Neurol."},{"issue":"4008","key":"10.1016\/j.neuint.2018.04.003_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.174.4008.523","article-title":"Sensory neglect produced by lateral hypothalamic damage","volume":"174","author":"Marshall","year":"1971","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.neuint.2018.04.003_bib50","series-title":"Ochratoxin a and Epigenetics. Handbook of Nutrition, Diet and Epigenetics","first-page":"1","author":"Mezzelani","year":"2017"},{"issue":"4","key":"10.1016\/j.neuint.2018.04.003_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1179\/1476830513Y.0000000108","article-title":"Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis","volume":"18","author":"Mezzelani","year":"2015","journal-title":"Nutr. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib52","first-page":"831","article-title":"Effects of the naturally occurring food mycotoxin ochratoxin A on brain cells in culture","volume":"18","author":"Monnet-Tschudi","year":"1996","journal-title":"Neurotoxicology"},{"issue":"9","key":"10.1016\/j.neuint.2018.04.003_bib53","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/S0021-9258(18)93832-9","article-title":"Tyrosine hydroxylase the initial step in norepinephrine biosynthesis","volume":"239","author":"Nagatsu","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2018.04.003_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.brainres.2010.07.076","article-title":"MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut","volume":"1355","author":"Natale","year":"2010","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0891-5849(94)90143-0","article-title":"The toxicity of high-dose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart","volume":"16","author":"Nelson","year":"1994","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib56","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2018.04.003_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000116351","article-title":"MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior","volume":"26","author":"Ogawa","year":"1987","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.neuint.2018.04.003_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuro.2013.11.001","article-title":"Attenuation of smoke induced neuronal and physiological changes by bacoside rich extract in Wistar rats via down regulation of HO-1 and iNOS","volume":"40","author":"Pandareesh","year":"2014","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mnfr.200600137","article-title":"Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans","volume":"51","author":"Pfohl-Leszkowicz","year":"2007","journal-title":"Mol. Nutr. Food Res."},{"issue":"10","key":"10.1016\/j.neuint.2018.04.003_bib60","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.neubiorev.2012.07.009","article-title":"Closing the gap between clinic and cage: sensori-motor and cognitive behavioural testing regimens in neurotoxin-induced animal models of Parkinson's disease","volume":"36","author":"Pienaar","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib61","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009308","article-title":"Modeling Parkinson's disease in primates: the MPTP model","volume":"2","author":"Porras","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"9","key":"10.1016\/j.neuint.2018.04.003_bib62","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2018.04.003_bib63","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","article-title":"Oxidative damage to proteins: spectrophotometric method for carbonyl assay","volume":"233","author":"Reznick","year":"1994","journal-title":"Meth. Enzymol."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2005.10.106","article-title":"Toxicokinetics and toxicodynamics of ochratoxin A, an update","volume":"159","author":"Ringot","year":"2006","journal-title":"Chem. Biol. Interact."},{"issue":"34","key":"10.1016\/j.neuint.2018.04.003_bib65","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1073\/pnas.0702753104","article-title":"Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice","volume":"104","author":"Rommelfanger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuint.2018.04.003_bib66","first-page":"197","article-title":"A marker of oxyradical-mediated DNA damage (8-hydroxy-2'deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain","volume":"3","author":"Sanchez-Ramos","year":"1994","journal-title":"Neurodegeneration"},{"issue":"7","key":"10.1016\/j.neuint.2018.04.003_bib67","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1158\/0008-5472.CAN-12-3767","article-title":"FOXO3a is a major target of inactivation by PI3K\/AKT signaling in aggressive neuroblastoma","volume":"73","author":"Santo","year":"2013","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jns.2006.06.006","article-title":"Can low level exposure to ochratoxin-A cause parkinsonism?","volume":"249","author":"Sava","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuro.2005.07.004","article-title":"Acute neurotoxic effects of the fungal metabolite ochratoxin-A","volume":"27","author":"Sava","year":"2006","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfm093","article-title":"Adult hippocampal neural stem\/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin-A","volume":"98","author":"Sava","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.neuint.2018.04.003_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1988.tb32972.x","article-title":"Aging-dependent emergence of sensorimotor dysfunction in rats recovered from dopamine depletion sustained early in life","volume":"515","author":"Schallert","year":"1988","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuint.2018.04.003_bib73","series-title":"Central Nervous System Diseases","first-page":"131","article-title":"Intervention strategies for degeneration of dopamine neurons in parkinsonism","author":"Schallert","year":"2000"},{"issue":"4336","key":"10.1016\/j.neuint.2018.04.003_bib74","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.564552","article-title":"Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats","volume":"199","author":"Schallert","year":"1978","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib75","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0091-3057(82)90452-X","article-title":"Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage","volume":"16","author":"Schallert","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neuint.2018.04.003_bib76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0091-3057(83)90019-9","article-title":"Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum","volume":"18","author":"Schallert","year":"1983","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neuint.2018.04.003_bib77","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2018.04.003_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molbrainres.2005.01.012","article-title":"Absence of inclusion body formation in the MPTP mouse model of Parkinson's disease","volume":"134","author":"Shimoji","year":"2005","journal-title":"Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.neuint.2018.04.003_bib82","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuroscience.2008.02.033","article-title":"Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease","volume":"153","author":"Tian","year":"2008","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib83","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib84","first-page":"205","article-title":"Other causes of parkinsonism","volume":"6","author":"Tison","year":"1997","journal-title":"Bailliere. Clin. Neurol."},{"issue":"6","key":"10.1016\/j.neuint.2018.04.003_bib85","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/bdrb.20022","article-title":"Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. II. Histopathological features of teratological anomalies induced in fetuses","volume":"71","author":"Wangikar","year":"2004","journal-title":"Birth Defects Res. Part B Dev. Reproductive Toxicol."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/carcin\/bgp264","article-title":"Mycotoxins and human disease: a largely ignored global health issue","volume":"31","author":"Wild","year":"2009","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.neuint.2018.04.003_bib87","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/ajcn\/80.5.1106","article-title":"Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions","volume":"80","author":"Williams","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.neuint.2018.04.003_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12263-008-0109-y","article-title":"Ochratoxin A induces apoptosis in neuronal cells","volume":"4","author":"Zhang","year":"2009","journal-title":"Genes Nutrit."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617305685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018617305685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T13:15:15Z","timestamp":1751548515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018617305685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":89,"alternative-id":["S0197018617305685"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2018.04.003","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restorative effect of l-Dopa treatment against Ochratoxin A induced neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}